Schizophrenia is a severe mental health disorder that affects an individual's perception of reality, emotions, and behaviour. While it is commonly diagnosed in late adolescence or early adulthood, it can also occur in children, a condition known as early-onset schizophrenia (EOS).

EOS is rare but profoundly impacts a child's development and quality of life.

Identifying Early-Onset Schizophrenia

Schizophrenia in children often manifests differently than in adults, making early identification challenging. Symptoms may begin subtly, mimicking other developmental or emotional issues. Key early signs include:

  1. Behavioural Changes: Withdrawal from family and peers, sudden academic decline, or loss of interest in previously enjoyed activities.
  2. Cognitive Impairment: Difficulty concentrating, disorganized thinking, or memory problems.
  3. Psychotic Symptoms: Hallucinations (hearing voices or seeing things that aren’t there) and delusions (persistent false beliefs).
  4. Mood Changes: Anxiety, irritability, or depressive symptoms.
  5. Speech or Movement Disorders: Unusual speech patterns, clumsiness, or repetitive movements.

How to Spot It Early?

Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia. If a child consistently displays several of the above symptoms for over six months, seeking an evaluation from a mental health professional is essential.

A detailed assessment, including interviews, psychological tests, and ruling out other conditions, is critical for an accurate diagnosis.

Is There an Increase in Cases?

While childhood-onset schizophrenia remains rare—affecting about 1 in 40,000 children, a perceived increase in cases may be attributed to improved diagnostic practices and awareness rather than an actual rise in prevalence.

Advancements in mental health care and education have led to earlier and more accurate identification of schizophrenia in children.

What May Cause Schizophrenia in Children?

The exact causes of schizophrenia are not fully understood, but it is believed to result from a combination of genetic, biological, and environmental factors:

  1. Genetic Predisposition: Children with a family history of schizophrenia are at higher risk.
  2. Brain Structure and Chemistry: Abnormalities in brain development and neurotransmitter function (dopamine and glutamate) are linked to schizophrenia.
  3. Prenatal Factors: Maternal infections, malnutrition, or complications during pregnancy may increase the risk.
  4. Stress and Trauma: High levels of stress or traumatic experiences during early development might trigger symptoms in genetically predisposed children.

Treatment Options

Early intervention is crucial for managing schizophrenia in children and improving long-term outcomes. Treatment typically involves a combination of approaches:

  1. Medication: Antipsychotic drugs help manage psychotic symptoms. These medications are often carefully chosen and monitored due to potential side effects in children.
  2. Therapy: Cognitive-behavioural therapy (CBT) can help children understand and cope with their symptoms. Family therapy provides support and improves communication within the household.
  3. Hospitalization: In severe cases, short-term hospitalization may be necessary to stabilize the child and ensure safety.

Importance of Early Diagnosis and Intervention

While schizophrenia in children presents significant challenges, early diagnosis and intervention can lead to meaningful improvements in functioning and quality of life.

Parents and caregivers should remain vigilant for unusual behaviours and seek professional guidance when concerns arise. Advances in research, medication, and therapy continue to offer hope for affected children and their families.

By fostering awareness and compassion, society can better support these young individuals as they navigate the complexities of living with schizophrenia. Early action can make all the difference in their journey toward stability and well-being.

Disclaimer: The views expressed in this article are of the author and not of Health Dialogues. The Editorial/Content team of Health Dialogues has not contributed to the writing/editing/packaging of this article.
Dr Sushma Gopalan
Dr Sushma Gopalan

Dr Sushma Gopalan (PhD, MA in Psychology, MSc in BT, PGDMH, PGDCRL) is a Child Psychologist and Child Life Specialist at Aster CMI Hospital, Bangalore, with over 8 years of experience. She holds a Doctorate in Clinical Psychology and double Master's degrees in Genetics and Counselling Psychology. Dr Sushma is certified in Guidance & Counselling, child development, and Suicide Prevention. She has expertise in managing pediatric ICU trauma, mental health support for children and families, psychological assessments, and therapies for a wide range of psychological issues. She is also a 2024 scholarship winner from the Association of Child Life Professionals (USA) and a member of various professional organizations.